Look up one drug

Ontario coverage, price, criteria word for word, Health Canada status and shortages for one product

Patient plan: look up a medication list

CLOXACILLIN

All products: general benefit

Other products in the same Health Canada class (J01C) — coverage varies; not interchangeable

  • Amoxicillin (Novamoxin): general benefit, Not a benefit, Listing status unconfirmed
  • Amoxicillin + clavulanic acid (Clavulin): general benefit, Not a benefit
  • Ampicillin (Penbritin): general benefit, Not a benefit
  • Penicillin v (Nadopen-V): general benefit, Not a benefit
  • Piperacillin + tazobactam (Tazocin): not a benefit

Teva-Cloxacillin · DIN 00337765 · 250mg · capsule

General benefitMarketed · checked 2026-09-02
StatusGeneral benefit
Write on scriptno code needed
Patient paysPatient pays: program not supplied; amount cannot be determined.
Private plan unknown: ask. If yes, check its coverage and payer coordination; if no, see the public routes below.
1 brand, same coverage
Teva-Cloxacillin · DIN 00337765 Manufacturer: Teva Canada Limited; listing date 1996-10-01 Daily cost (source): $0.8564 Health Canada: Marketed since 2016-09-29 · brand TEVA-CLOXACILLIN · ATC J01CF02 CLOXACILLIN · form Capsule · route Oral · ingredients CLOXACILLIN (CLOXACILLIN SODIUM) 250 MG · company Teva canada limited · schedule Prescription
Check this DIN again · Health Canada product record

Teva-Cloxacillin: Formulary list price $0.2141/unit (unit not stated in source; not the patient's cost)

Ministry pays: $0.2141 per source unit.

Source explanation: The formulary price is what ODB pays; the cash price at the counter is set by the pharmacy.

Formulary data: Ontario extract of Aug 26, 2026 · Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=2233 · Verify on the e-Formulary ↗ (DIN 00337765)

Source record
DIN 00337765: Teva-Cloxacillin Raw flags: sec3=Y Item: 081216008; group id 28; item number 0057; lccId None; manufacturer id TEV Source form: Cap; strength: 250mg Recorded listing: General benefit Source prices (unrounded): $0.2141; ministry $0.2141 Source: ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26 DIN=00337765 Health Canada DPD extract of Sep 2, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=2233
Interchangeable products
Jamp Cloxacillin · DIN 02510731 · $0.2141 Orbenin · DIN 00002046 · not recorded
Shortage status: resolved shortage (ended 2022-09-22); reports as of 2026-09-13T08:10:21.292534+00:00 (Health Product Shortages Canada) Source: https://healthproductshortages.ca/search?term=00337765
Shortage record checked 2026-09-13T08:10:21.292534+00:00
Other drugs in the same formulary class (08:12:16 Penicillins) and how they are covered

Matched class: 08:12:16 Penicillins

Drug-class inventory only. Lists recorded Ontario formulary products, not every Canadian medication; does not recommend treatment. Some products covered without a code (check the product listing): AMOXICILLIN, AMOXICILLIN & CLAVULANIC ACID, AMPICILLIN, PENICILLIN V (POTASSIUM) 08:12:16 Penicillins

AMOXICILLIN

· 36 products · General benefit (27), Listed, not a benefit (4), Off-Formulary Interchangeable, not an ODB benefit (4), Temporary benefit (1) · strengths: 250mg, 500mg, 125mg, 25mg/mL, 50mg/mL · Cap, Chew Tab, O/L, Pd for Oral Susp

AMOXICILLIN & CLAVULANIC ACID

· 25 products · General benefit (22), Listed, not a benefit (3) · strengths: 25mg & 6.25mg/mL, 50mg & 12.5mg/mL, 200mg & 28.5mg/5mL, 400mg & 57mg/5mL, 250mg & 125mg, 500mg & 125mg, 875mg & 125mg · O/L, Susp, Tab

AMPICILLIN

· 4 products · Listed, not a benefit (2), General benefit (2) · strengths: 250mg, 500mg · Cap

PENICILLIN V (POTASSIUM)

· 4 products · Listed, not a benefit (2), General benefit (2) · strengths: 25mg/mL, 300mg · O/L, Tab

PIPERACILLIN SODIUM & TAZOBACTAM SODIUM

· 18 products · Off-Formulary Interchangeable, not an ODB benefit · strengths: 2g & 250mg, 3g & 375mg, 4g & 500mg · Inj Pd-2.25g Vial Pk, Inj Pd-3.375g Vial Pk, Inj Pd-4.5g Vial Pk Source: formulary-ed43-front-matter.txt Part V; ODB odb-formulary-ed43-extract-2026-08-26.xml extract_date=2026-08-26; class 08:12:16
Full class listing Related classes: 08:12:04 Antifungals, 08:12:07 Carbapenems, 08:12:12 Erythromycins, 08:12:24 Tetracyclines, 08:12:28 Other Antibiotics, 08:14:08 Azoles Same formulary class, not same indication: class membership alone does not establish equivalent uses.
What the Health Canada label says it is for
INDICATIONS AND CLINICAL USE TEVA-CLOXACILLIN (cloxacillin sodium) finds use in the treatment of infections caused by streptococci when associated with sensitive penicillinase-producing staphylococci; also in the treatment of all staphylococcal infections, whether penicillin G-sensitive or resistant. In infections suspected of being caused by penicillinase-producing staphylococci, cloxacillin may be used for initial treatment after appropriate specimens have been taken for culture and before results of microbial susceptibility tests are known. If the results of identification and susceptibility tests indicate that the infecting organism is not a penicillinase-producing staphylococcus susceptible to cloxacillin, cloxacillin should be discontinued and treatment with an appropriate alternative agent instituted. To reduce the development of drug-resistant bacteria and maintain the effectiveness of TEVA- CLOXACILLIN and other antibacterial drugs, TEVA-CLOXACILLIN should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, th… https://pdf.hres.ca/dpd_pm/00055444.PDF PM date: March 17, 2020 Source product: TEVA-CLOXACILLIN; DIN 00337757; fetched 2026-09-10 Product monograph posted by Health Canada; excerpt for lookup only.